Brian Schwartz
Cyclacel Pharmaceuticals (United Kingdom)
ORCID: 0000-0003-2632-6351Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: βPreclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemiaβ.
Abeera Mehmood, Jae Yoon Jeon, Bridget Carmichael, Amy Lehman, Shelley Orwick +13 more
Shalina Joshi, Shuai Ye, Martin G. Belinsky, Dinara Sharipova, Jeffrey M. Farma +9 more
Shalina Joshi, Shuai Ye, Martin G. Belinsky, Dinara Sharipova, Jeffrey M. Farma +9 more
Brian Schwartz, Sahithi Lakamana, Yao Ge, Abeed Sarker, Shaina Raza